baber/WOPTO huggingface dataset:
Patent JP-2000513797-A (JP)
Title: 冷凍システム
IPC: F25B41/04
Filed: 1997-11-12
Abstract: (57)【要約】
この冷凍システムでは、凝縮器の中の中の冷媒の相変化推移温度と凝縮器の出力側の液体冷媒の温度との間の温度差に基づいて凝縮器から受液器に送られる冷媒の総量を制御することによって過冷却を制御している。冷媒は、システムが相変化温度と予め決められた値を越える液体温度との間の差が凝縮器の圧力結果になるまで蓄積されて受液器から流出される。コントローラは、受液器の入力側のブリード弁と、凝縮器から受液器の中に冷媒を引き寄せる出力側の開放弁とを同時に作動させることによってこの条件に反応する。従って、凝縮圧力が下がり、相変化温度と液体温度との間の差は要求される総量の方向に減少する。そして、再びサイクルが始まる。
Patent JP-2000514916-A (JP)
Title: ガスバーナ
IPC: F23D14/16
Filed: 1998-05-02
Abstract: (57)【要約】
本発明は、ケーシングを備えたガスバーナであって、前記ケーシングが、ガス又はガス・空気混合物のための入口と排ガスのための出口とを備えた燃焼室を有しており、燃焼室内に、多孔性の材料から成る少なくとも１つの燃焼体が配置されていて、この燃焼体内でガス・空気混合気が燃焼せしめられ、この際に、燃焼体が、少なくとも２つの部分燃焼体に分けられていて、燃焼体に冷却装置が配属されている形式のものに関する。燃焼体が、冷却装置に向いた側の、少なくとも熱発生領域内で１つの部分燃焼体を形成していて、該部分燃焼体が、冷却装置とは反対側の部分燃焼体よりも小さい流れ抵抗を有していることによって、高い出力が得られ、それと同時に有害物質は低く維持される。
Patent JP-2002508750-A (JP)
Title: 化学的方法
IPC: C07C63/70
Filed: 1997-05-14
Abstract: (57)【要約】
式：Ｒ 1 ＣＯ 2 Ｈ［式中、Ｒ 1 は置換されてもよいアリール、置換されてもよいヘテロアリール、又はアリールによって置換されてもよいアルケニルである］で示されるカルボン酸の製造方法であって、式：Ｒ 1 ＣＨ 2 ＯＨのアルコール又は式：Ｒ 1 ＣＨＯのアルデヒドを塩基、触媒量の銅塩及び適当なリガンドの存在下；任意に添加剤の存在下で、酸素と反応させることを含む製造方法。
Patent MD-20010405-A (MD)
Title: Fuel system of the internal combustion engine
Inventor: GABAREV ION
IPC: F23D11/26
Filed: 2001-12-12
Abstract: The invention relates to the automotive industry and may be used in the fuel systems of the internal combustion engines.The system contains an electric low-pressure pump, a pressure detector, a microprocessor, a pipe-line for fuel, an injector, a valve, a piezoelectric element.
Patent MD-20020030-A (MD)
Title: Method of reposition of the cotyloid cavity bottom fractures
Inventor: KUSTUROV VLADIMIR
IPC: A61B17/56
Filed: 2001-12-27
Abstract: The invention refers to medicine, namely to orthopedics and traumatology and is destined for treatment of the patients with cotyloid cavity bottom fractures. Summary of the invention consists in that into the femur head and into the dislocated fragment of the cotyloid cavity bottom there is introduced a fixing device, then under the laparoscopic control on the inner surface of the cotyloid cavity bottom it is formed a support and it is dislocated the femur with the fixed fragment up to their reposition. Additionally, the femur is laterally deviated and there are made passive movements in the hip articulation within the limits of 15...18 degree  with the angular displacement velocity not exceeding the pain threshold.The result of the invention consists in increasing the reliability of fragments adaptation and in excluding the traumatism of the neighbouring with the hip articulation malacotic tissues.Claims: 1
Patent MX-159333-A (MX)
Inventor: ABRAMSON EDWARD ANTON
IPC: G03C5/00
Filed: 1982-02-16
Abstract: Contacting a rough cut optical fiber end to a light-transmissible, hardenable material supported on a smooth substrate and thereafter hardening the material to form a smooth flat light transmissible surface at the end of the fiber.
Patent MX-162674-A (MX)
Inventor: PIERRE PATRICK
IPC: G11B33/04
Filed: 1985-07-09
Abstract: Arrangement constituted by a stack of boxes intended to contain drawers, in particular for the storage of audio and video recording tapes. The boxes have different dimensions. The widths and heights of the boxes are dimensioned to adapt to the contents and to allow a large number of combinations. On their upper side, the boxes comprise profiled ribs on which are fitted grooves of matching profile provided on a lower side of the boxes.
Patent NO-20022116-A (NO)
Inventor: BJØRSHOL NILS HARALD
IPC: B63B35/26
Filed: 2002-05-02
Abstract: A method for unloading of two different separated populations (p1, p2) of fish in a fish carrier, in which said populations are situated at either end of a bulkhead (6) with a separation grating (60) in a transport tank (0), said grating apertures in said separation grating (60) being restricted to a grating aperture which is less than the individuals in both populations (p1, p2), and the tank being provided with at least one forward inlet (46) for fresh water, and at least one aft outlet (42) for water and fish, comprising the following steps: i) said bulkhead (6) with said separation grating (60) displaces one of the populations (p2) against said outlet (42), so that said population (p2) is forced through said outlet (42); characterized by ii) opening said separation grating (60) and running said bulkhead (6) towards said inlet (46) to a position closer to said inlet (46) than a desired portion, preferably all, of the population (p1); iii) restricting said grating apertures in said separation grating (60) to a grating aperture which is less than the individuals in said population (p1) and running said bulkhead (6) astern, so that said bulkhead (6) with said separation grating (60) displaces said second population (p1) towards said outlet (42) so that said population (p1) is forced through said outlet (42).
Patent NZ-203034-A (NZ)
Title: 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinone derivatives
Inventor: PEET N P
IPC: C07D257/06
Filed: 1983-01-14
Abstract: 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinones useful as antiallergic agents are described herein. The compounds are prepared by the reaction of an appropriate 2-amino-N-(1H-tetrazol-5-yl)benzamide with an appropriate ortho ester.
Patent NZ-212419-A (NZ)
Title: In vitro diagnostic test for detecting cancer cells producing mucin antigens
Inventor: LINNANE A W
IPC: A61K39/395
Filed: 1985-06-14
Abstract: PCT No. PCT/AU85/00136 Sec. 371 Date Apr. 24, 1986 Sec. 102(e) Date Apr. 24, 1986 PCT Filed Jun. 21, 1985 PCT Pub. No. WO86/00414 PCT Pub. Date Jan. 16, 1986.An in vitro diagnostic method for detecting the presence in a patient of cancer cells or other cells producing mucin antigens comprises the step of testing a sample of a physiological fluid, particularly a sample of blood, blood serum or blood plasma, taken from the patient to detect the presence of small intestine mucin antigen (SIMA) and/or large intestine mucin antigen (LIMA) in the sample. An in vitro diagnostic kit is also disclosed.
Patent NZ-227939-A (NZ)
Title: 2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)-thieno-(2,3-d) isothiazol-3(2h)one-1,1-dioxide derivatives; preparatory processes and pharmaceutical compositions
Inventor: BINDER DIETER
IPC: C07D513/04
Filed: 1989-02-10
Abstract: Novel basically substituted 5-halothienoisothiazole- 3(2H)-one-1,1-dioxides of the formula 
<IMAGE>
 in which
 R1 represents hydrogen, (C1-C4)-alkyl or halogen,
 R2 represents halogen and
 n represents an integer from 2 to 6, their pharmaceutically tolerable acid addition salts, a process for their preparation and their use in medicaments for the treatment of anxiety states.
Patent NZ-233901-A (NZ)
Title: Aminoalkyl-substituted benzophenone derivatives and analogues, pharmaceutical compositions and precursor compounds
Inventor: GUERRY PHILIPPE
IPC: C07C225/10
Filed: 1990-06-01
Abstract: The compounds of the general formula 
<IMAGE>
 in which R<1> and R<2> each denote hydrogen, lower alkyl or lower alkenyl or together denote straight-chain alkylene having 2 to 4 carbon atoms, R<3> denotes hydrogen, halogen or lower alkyl, Q denotes alkylene having 2 to 11 carbon atoms and at least 2 carbon atoms between the two free valencies or alkenylene having 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies and Y and Y' each denote a direct bond or the group -CH2-, -CH2CH2-, -CH=CH- or -C IDENTICAL C-, the group R<1>R<2>N-Q-CH2- is bonded to the 3- or 4-position of the ring designated A, and the symbol R denotes that the ring is unsubstituted or substituted by halogen, trifluoromethyl, cyano, nitro, lower alkyl or lower alkoxy,
 and their pharmaceutically acceptable acid addition salts have useful pharmacological properties. In particular, they have a pronounced antifungal action and exhibit synergistic effects in combination with known antifungal substances which inhibit sterol biosynthesis, such as ketoconazole and terbinafine. The compounds of the formula I can therefore be used as medicaments, in particular for the control or prevention of topical or systemic infections which are caused by pathogenic fungi.
Patent NZ-234249-A (NZ)
Title: Optionally heterocyclically-substituted pyridine derivatives and pharmaceutical compositions
Inventor: EFFLAND RICHARD CHARLES
IPC: C07D213/75
Filed: 1990-06-26
Abstract: There are described compounds of the formula <CHEM>  where  n is 0 or 1; X is O or NR2, R2 being hydrogen, loweralkyl or loweralkylcarbonyl; Z is NO2 or NHR where R is hydrogen, loweralkyl, arylloweralkyl or loweralkylcarbonyl; and  R1 is <CHEM>   <CHEM> wherein R3 is hydrogen, loweralkyl or loweralkylcarbonyl; m is 1 or 2; each R4 is independently hydrogen or loweralkyl; and Y is hydrogen, halogen, loweralkyl, loweralkoxy or trifluoromethyl; which compounds are useful as topical antiinflammatory agents for the treatment of various dermatoses.
Patent NZ-246156-A (NZ)
Title: 4-anilino-1,8-naphthyridine derivatives and pharmaceutical compositions
Inventor: ARMITAGE BERNARD JOHN
IPC: A61K31/44
Filed: 1992-12-12
Abstract: PCT No. PCT/EP92/02901 Sec. 371 Date Jun. 3, 1994 Sec. 102(e) Date Jun. 3, 1994 PCT Filed Oct. 12, 1992 PCT Pub. No. WO93/13097 PCT Pub. Date Jul. 8, 1993.This invention relates to compounds of formula I and pharmaceutically acceptable salts thereof kyl, hydroxy, carboxyalkenyl, alkoxycarbonyalkenyl, hydroxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, alkoxy, halogenated alkyl, carboxy alkoxycarbonyl or alkanoylamino; R2 represents hydrogen, halo, alkoxy, hydroxy, alkanoyloxy, or phenoxy; R3 represents hydrogen or alkyl; R4 represents hydrogen, halo, alkoxycarbonyl, a benzyloxycarbonyl, alkanoyl, benzoyl, carbamoyl, alkyl, carboxy, hydroxyalkyl or alkylthio; R5 represents hydrogen or alkyl; R6 represents hydrogen, alkyl [optionally substituted by one or more of the following: hydroxy, halo or an amino group of formula -NR12R13], a C3-12 alicyclic hydrocarbon group, phenyl, (cycloalkyl)alkyl or benzyl; R7 represents hydrogen, halo, trifluoromethyl, trifluoromethoxy, alkyl, carboxy, or alkoxy; R8 represents hydrogen, halo, trifluoromethyl, trifluoromethoxy, alkyl or alkoxy; and R9 represents hydrogen or alkyl; which are antirheumatic agents. Compositions containing these compounds and processes to make them are also disclosed.
Patent NZ-255451-A (NZ)
Title: Optically active hydroquinine 1-(3-aminophenyl) ethanesulphonate (form a) and use in preparation of enantiomers of n-3-(1-sulphoethyl)phenyl urea derivatives
Inventor: GUYON CLAUDE
IPC: C07D/
Filed: 1993-09-06
Abstract: PCT No. PCT/FR93/00848 Sec. 371 Date Mar. 10, 1995 Sec. 102(e) Date Mar. 10, 1995 PCT Filed Sep. 6, 1993 PCT Pub. No. WO94/06792 PCT Pub. Date Mar. 31, 1994This invention relates to an optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate (form A), preparation thereof and its use as an intermediate in the preparation of cholecystokinine and gastrin antagonists.
Patent NZ-260858-A (NZ)
Title: Locking pliers: asymmetric angular jaw configuration for large cylindrical workpieces
Inventor: TYSER GENE LEE
IPC: B25B3/00
Filed: 1994-06-27
Abstract: The pliers includes a body, and a fixed jaw secured to the body and comprising a first working surface, the first working surface comprising a first end portion, a first intermediate portion, and a first concave inner portion. There is a movable jaw pivotably mounted to the body to pivot w.r.t. the fixed jaw about a pivot axis that is fixed w.r.t. the body. The movable jaw comprises a second working surface opposed to the first working surface, the second working surface comprising a second end portion, a second intermediate portion, and a second concave inner portion. There is an over-center toggle linkage secured between the movable jaw and the body to pivot the movable jaw about the pivot axis and to lock the movable jaw in position w.r.t. the fixed jaw. The first concave inner portion extends over an arc alpha of at least 45 deg.C, the second concave inner portion extending over an arc beta of at least 80 deg.C and greater than the arc alpha.
Patent NZ-264302-A (NZ)
Title: 5-acyl-3-amino-tetrahydronaphthalenes and chromanes
Inventor: HOECHSTETTER CRAIG STEVEN
IPC: A61P25/00
Filed: 1994-08-24
Abstract: Isoxazole derivs. of formula (I) and their acid-addn. salts and solvates are new: In (I) R = 1-4C alkyl, allyl or cyclopropylmethyl; R1 = H, 1-4C alkyl, allyl, cyclopropylmethyl or aryl(1-4C)alkyl; X = CH2 or O; y = 4-R2-5-R3-3-isoxazolyl or 3-R2-4-R3-5-isoxazolyl; R2 and R3 = H, 1-4C alkyl, 1-4C alkoxy, 1-4C alkylthio, OH, NH2, CN or Ph. Pref. x = CH2; R and R1 = 1-4C alkyl, esp. n-Pr; R2 and R3 = H.
Patent NZ-278675-A (NZ)
Title: Pyrrolopyridazine derivatives; medicaments
Inventor: KIMURA TOMIO
IPC: C07D487/04
Filed: 1995-01-18
Abstract: Pyrrolopyridazine derivatives having the general formula. <CHEM> ÄIn the above formula, R<1> represents a C2-C6 alkenyl group, a halogeno-C2-C6-alkenyl group, a C6-C10 aryl-C2-C6-alkenyl group, a C2-C6 alkynyl group, a C3-C7 cycloalkyl group, a C3-C7 cycloalkyl-C1-C6-alkyl group, a C5-C7 cycloalkenyl-C1-C6-alkyl group or a halogeno-C1-C6-alkyl group; R<2> and R<3> are the same or different and each represents a hydrogen atom, a C1-C6 alkyl group or a C6-C10 aryl group; R<4> represents a hydrogen atom or a C1-C6 alkyl group; R<5> represents a C6-C10 aryl group or a 5-10 membered heteroaryl group comtaining heteroatom(s) selected from nitrogen, oxygen and sulfur; A represents a C1-C3 alkylene group; X represents an imino group, an oxygen atom, a sulfur atom or a methylene group; m represents 0 or 1; and n represents 0 or 1Ü  or pharmaceutically acceptable salts thereof. <H0> ÄEffectÜ </H0> The pyrrolopyridazine derivatives of the present invention have an excellent gastric secretion inhibiting activity, gastric mucosa protective activity and antibacterial activity against Helicobacter pylori, and are useful as a preventive or therapeutic agent for ulcerous diseases.
Patent NZ-282402-A (NZ)
Title: Silyl derivatives; compounds and use in epimer enrichment of pregna-1,4-diene-3,20-dione derivatives
Inventor: GUTTERER BEATE
IPC: C07J71/00
Filed: 1995-03-07
Abstract: PCT No. PCT/EP95/00836 Sec. 371 Date Nov. 25, 1996 Sec. 102(e) Date Nov. 25, 1996 PCT Filed Mar. 7, 1995 PCT Pub. No. WO95/24416 PCT Pub. Date Sep. 14, 1995The invention describes a process for the epimer enrichment of compounds of formula (I) by silation, fractionated crystallization and acid hydrolysis.    <IMAGE>  (I)
Patent NZ-326155-A (NZ)
Title: Use of compounds that bind selectively or specifically to RAR-alpha retinoid receptors for treating tumours
Inventor: TENG MIN
IPC: A61P17/02
Filed: 1996-12-16
Abstract: A retinoid compound that binds specifically or selectively to a RARa-retinoid receptors in the manufacture of a medicament for treating or preventing a disease or condition which is responsive to treatment by RARa specific or selective retinoid agonists provided that the disease or condition is not acute promyelocytic leukemia, acne, psoriasis or photo damage to the skin. The retinoid compound can have the formula I or II wherein: X1 is O or -[C(R1)2]n and n is 0 to 2; each R1 and R2 are independently H or alkyl; R3 is H, F or alkyl; m is 0-5; o is 0-4; p is 0-2; r is 0-2; X2 is N or CH; Y is an optionally substituted phenyl, naphthyl, pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl or pyrazolyl; W and W2 are independently F, Br, Cl, I, fluoro substituted alkyl, NO2 or OH; W3 is F, Br, Cl, I, fluoro substituted alkyl, alkyl, NO2 or OH; L is -(C=Z)-NH- or -NH-(C=Z)-; Z is O or S; B is COOH or a pharmaceutically salt thereof, COOR8, CONR9R10, CH2OH, CH2OR11, CH2OCOR11, CHO, CH(OR12)2, CHOR13O, COR7, CR7(OR12)2, CR7OR13O and the rest of the variables are defined in the specification limited by the provisos as listed in the specification;
Patent NZ-332445-A (NZ)
Title: Steel-framed building construction with pre-assembled frames for walls, ceilings, roof and roof supports
Inventor: GAVIN PETER GEOFFREY
IPC: E04C3/04
Filed: 1998-10-21
Abstract: Provided is a steel frame building having wall frames (external and/or internal), one or more substantially planar ceiling frames supported by the wall frames, a roof structure including one or more inclined substantially planar roof frames extending substantially parallel to associated roof surfaces which the roof frames support, and support means extending between the one or more roof frames and the one or more ceiling frames to transfer the weight of the roof structure to one or more ceiling frames and the support means through the wall frames. The figure illustrates a planar roof fame 76 in its inclined position.  The roof frame is provided with a support means between the planar roof frame and the ceiling frames in the form of a central ridge frame 70.  An intermediate support 74 may also be provided to support the roof frame 76, but it is removed from the figure drawing for clarity.
Patent NZ-334426-A (NZ)
Title: Characterising cDNA comprising cutting sample cDNAs with a first endonuclease, sorting fragments according to the un-paired ends of the DNA, cutting with a second endonuclease then sorting the fragments
Inventor: SCHMIDT GUNTER
IPC: C12Q1/6837
Filed: 1997-09-05
Abstract: A method for characterising cDNA, which comprises: (a) cutting a sample comprising a population of one or more cDNAs or isolated fragments thereof, each having a strand complementary to the 3' poly-A terminus of an mRNA and bearing a tail, with a first sampling endonuclease at a first sampling site of known displacement from a reference site proximal to the tail to generate from each cDNA or isolated fragment thereof a first and second sub-fragment, each comprising a sticky end sequence of predetermined length and unknown sequence, the first sub-fragment bearing the tail; (b) sorting either the first or second sub-fragments into sub-populations according to their sticky end sequence and recording the sticky end sequence of each sub-population as the first sticky end; (c) cutting the sub-fragments in each sub-population with a second sampling endonuclease, which is the same as or different from the first sampling endonuclease, at a second sampling site of known displacement from the first sampling site to generate from each sub-fragment a further sub-fragment comprising a second sticky end sequence of predetermined length and unknown sequence; and (d) determining each second sticky end sequence; wherein the aggregate length of the first and second sticky end sequences of each sub-fragment is from 6 to 10; and wherein the sequences and relative positions of the reference site and first and second sticky ends characterise the or each cDNA.
Patent NZ-500180-A (NZ)
Title: Cyanamide hydratase (cah) as a plant selection marker providing cyanamide tolerance
Inventor: DAMM BRIGITTE
IPC: C12N9/88
Filed: 1998-04-17
Abstract: Cyanamide hydratase may be used as a selection marker in plant transformation. Plants transformed with the gene coding for cyanamide hydratase are able to convert the cyanamide into urea.  As cyanamide acts as a herbicide, transformed plants may be selected by growing the plants in a medium comprising cyanamide.
Patent NZ-503595-A (NZ)
Title: Automated validation and verification of computer software
Inventor: GOOSSEN EMRAY R
IPC: G06F11/36
Filed: 1998-09-24
Abstract: A method and apparatus for automating validation and verification of computer software that confirms during a test execution of the software that all lines of code are executed and all branches in the software are taken or not taken at least once. The computer software to be tested is compiled and a link map is generated. After compilation of the code, it is run in a test fixture to test all the required functions. During this test execution, a monitoring process is performed which documents which lines of code have been executed and whether certain branches of the code were either taken or not taken. An execution record is generated which indicates what instruction branches were taken and were not taken. A comparison is then made between the link map originally generated and the instruction record generated to determine what lines of code were executed, whether each branch was taken at least once, and whether a branch was not taken at least once.
Patent NZ-504133-A (NZ)
Title: Active acoustic devices with edge of panel member clamped to effect resonant bending wave modes
Inventor: AZIMA FARAD
IPC: H04R7/04
Filed: 1999-01-15
Abstract: An active acoustic device comprises a panel member (11) having distribution of resonant modes of bending wave action determining acoustic performance in conjunction with transducer (31-34).  The transducer (31-34) is coupled to the panel member (11) at a marginal position to result in acoustically acceptable action dependent on the distribution of active resonant modes.  Methods of selecting the transducer location rely on assessing best or better operative interaction of transducer means (31-34) and the panel members (11) according to parameters of acoustic output for the device as an acoustic radiator.
Patent NZ-504287-A (NZ)
Title: Spiral ribbed circular saw blades
Inventor: IZARD NOWELL WILLIAM
IPC: B23D61/02
Filed: 2000-05-02
Abstract: A method of manufacturing a tungsten carbide tipped circular saw blade characterised by the steps of: a) supplying a sheet steel strip or blank to a laser cutting machine; b) laser cutting an arbor and the periphery profile of a blade according to a predetermined computer controlled pattern; c) pressing a rib pattern into the blade; d) brazing tungsten carbide saw tips at respective locations on the periphery of the blade; and e) grinding the final cutting profile to each of the tungsten carbide tips.
Patent NZ-505112-A (NZ)
Title: A fittings with inwardly displaced joints for use with ducting
Inventor: COOKE ROGER LAURENCE
IPC: F16L21/06
Filed: 2000-06-13
Abstract: A connector consists of two substantially identical half-shells (2,4), which differ only in the construction of the inwardly displaced joint formations (6,12) at the abutting faces (8a and 14a) to provide positive location and sealing along a median plane of the connector.  The upper shell half (2) is formed with the male joint parts (6) which consists of a transverse projection (8) directed laterally inwardly having an outer face (8a) lying on the median plane of the assembled connector and has at its inner end a longitudinal projection (10) which extends outwardly of the half-shell (2) beyond the face (8a).   The lower half-shell (4) includes the corresponding female joint parts (12) each consisting of a transverse projection (14) extending laterally inwardly, an outer face (14a) which, in the assembled connector, abuts against the face (8a) and a first projection (16), which extents inwardly of the half-shell and carries at its inner end a second longitudinal projection (18) spaced laterally inwardly of the projection (16) and outwardly of the half-shell (4). The connector can take any suitable any suitable form such as a straight or angled connector, or a branch of Y or T form.
Patent NZ-505518-A (NZ)
Title: Fruit harvester having a shaker assembly with elongate shaker members that have flexible rods which are of an oblong cross-section and have an elongate base
Inventor: MERANT JEAN-CAMILLE
IPC: A01D46/28
Filed: 2000-01-25
Abstract: In this harvesting machine using shaker members in the form of rods to shake the fruit-bearing bushes and harvest the fruit, each shaker rod has an elongate base part which has, in use, a required flexibility characteristic for the rod in a horizontal plane and which has an oblong cross-section whose height is greater than its width, said cross-section having two main geometrical axes which are respectively horizontal and vertical and dimensions of height and width such that its moment of area about the horizontal main axis is significantly greater than its moment of area about the vertical main axis and its height is less than a predefined value. The base part forms a core for the rod, which can further include a wear part which covers the core and which is made of a material and has a thickness such that the rod has flexibility characteristics in the horizontal and vertical planes that are practically unchanged relative to those of the core, even after substantial wear of the wear part